Citation: Hm. Bryson et D. Faulds, CISATRACURIUM BESILATE - A REVIEW OF ITS PHARMACOLOGY AND CLINICAL POTENTIAL IN ANESTHETIC PRACTICE, Drugs, 53(5), 1997, pp. 848-866
Citation: R. Davis et al., NEFAZODONE - A REVIEW OF ITS PHARMACOLOGY AND CLINICAL EFFICACY IN THE MANAGEMENT OF MAJOR DEPRESSION, Drugs, 53(4), 1997, pp. 608-636
Citation: Ss. Patel et al., FOSFOMYCIN TROMETHAMINE - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC EFFICACY AS A SINGLE-DOSE ORALTREATMENT FOR ACUTE UNCOMPLICATED LOWER URINARY-TRACT INFECTIONS, Drugs, 53(4), 1997, pp. 637-656
Citation: Kl. Goa et al., SPARFLOXACIN - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES, CLINICAL EFFICACY AND TOLERABILITY IN LOWER RESPIRATORY-TRACT INFECTIONS, Drugs, 53(4), 1997, pp. 700-725
Citation: Aj. Wagstaff et Hm. Bryson, TIZANIDINE - A REVIEW OF ITS PHARMACOLOGY, CLINICAL EFFICACY AND TOLERABILITY IN THE MANAGEMENT OF SPASTICITY ASSOCIATED WITH CEREBRAL AND SPINAL-DISORDERS, Drugs, 53(3), 1997, pp. 435-452
Citation: Ss. Patel et al., EPIDURAL CLONIDINE - A REVIEW OF ITS PHARMACOLOGY AND EFFICACY IN THEMANAGEMENT OF PAIN DURING LABOR AND POSTOPERATIVE AND INTRACTABLE PAIN, CNS DRUGS, 6(6), 1996, pp. 474-497
Citation: Hm. Bryson et Mi. Wilde, AMITRIPTYLINE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE IN CHRONIC PAIN STATES, Drugs & aging, 8(6), 1996, pp. 459-476
Citation: Ap. Lea et al., POTENTIALLY SERIOUS ADVERSE EVENTS SUCH AS PRIAPISM (GREATER-THAN-6 HOURS DURATION) AND FIBROSIS OCCURRED IN 0.4 AND 8-PERCENT OF PATIENTS (VOL 8, PG 57, 1996), Drugs & aging, 8(5), 1996, pp. 357-357
Citation: Ap. Lea et al., INTRACAVERNOUS ALPROSTADIL - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND THERAPEUTIC POTENTIAL IN ERECTILE DYSFUNCTION, Drugs & aging, 8(1), 1996, pp. 56-74
Citation: Hm. Bryson et al., RILUZOLE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND THERAPEUTIC POTENTIAL IN AMYOTROPHIC-LATERAL-SCLEROSIS, Drugs, 52(4), 1996, pp. 549-563
Citation: M. Haria et al., ITRACONAZOLE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE IN THE MANAGEMENT OF SUPERFICIAL FUNGAL-INFECTIONS (VOL 51, PG 594, 1996), Drugs, 52(2), 1996, pp. 253-253
Citation: M. Haria et al., ITRACONAZOLE - A REAPPRAISAL OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE IN THE MANAGEMENT OF SUPERFICIAL FUNGAL-INFECTIONS, Drugs, 51(4), 1996, pp. 585-620
Citation: Ja. Balfour et al., IMIPENEM CILASTATIN - AN UPDATE OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETICS AND THERAPEUTIC EFFICACY IN THE TREATMENT OF SERIOUS INFECTIONS/, Drugs, 51(1), 1996, pp. 99-136
Citation: Aj. Wagstaff et Hm. Bryson, CLOZAPINE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE IN PATIENTS WITH SCHIZOPHRENIA WHO ARE UNRESPONSIVE TO OR INTOLERANT OF CLASSICAL ANTIPSYCHOTIC AGENTS, CNS DRUGS, 4(5), 1995, pp. 370-400
Citation: Cm. Perry et Hm. Bryson, OKA MERCK VARICELLA VACCINE - A REVIEW OF ITS IMMUNOGENICITY AND PROTECTIVE EFFICACY AGAINST VARICELLA/, CLINICAL IMMUNOTHERAPEUTICS, 4(5), 1995, pp. 396-416
Citation: Cm. Spencer et Hm. Bryson, TEICOPLANIN - A PHARMACOECONOMIC EVALUATION OF ITS USE IN THE TREATMENT OF GRAM-POSITIVE INFECTIONS, PharmacoEconomics, 7(4), 1995, pp. 357-374
Citation: C. Rains et Hm. Bryson, TOPICAL CAPSAICIN - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC POTENTIAL IN POSTHERPETIC NEURALGIA, DIABETIC NEUROPATHY ANDOSTEOARTHRITIS, Drugs & aging, 7(4), 1995, pp. 317-328
Authors:
WISEMAN LR
WAGSTAFF AJ
BROGDEN RN
BRYSON HM
Citation: Lr. Wiseman et al., MEROPENEM - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND CLINICAL EFFICACY, Drugs, 50(1), 1995, pp. 73-101